Virax Biolabs Group Ltd
VRAX · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $0.0B · 19 employees
Latest Stock Quote
VRAX 2026-06-02
$0.2163
O:$0.1773 H:$0.219 L:$0.1721 Vol:16.9M VWAP:$0.2524
origin leaf: 1e7e7c9d9474504551258998484fe9a3b8da10dc76e15e7216fb68867ff4ca84
66 total filings indexed. 66 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001885827 |
| Ticker | VRAX |
| Exchange | Nasdaq |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | E9 |
| Website | https://www.viraxbiolabs.com |
| Listed | 2022-07-21 |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: df62da17572c59a0785373ef87b363482269e0b0e8c1a2cb5532d95cc53a6fa3
parent: f2a8767488d0c8da6fe98fdf14c1cd170ca9ef5cc51a7253b3a6bcb56c725282
content hash: 27aa56499b7412e2ca47b418e982f8ec5616254c59f7e8b97b4844d03c6c8c62
signed: 2026-06-03T12:02:59.835Z
sources: 1 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf